StockNews.com Upgrades Senseonics (NYSE:SENS) to Sell

Senseonics (NYSE:SENS) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Monday.

A number of other equities research analysts have also recently commented on SENS. HC Wainwright reissued a “buy” rating and set a $2.00 price target on shares of Senseonics in a report on Wednesday, March 5th. Mizuho began coverage on shares of Senseonics in a report on Thursday, April 10th. They set an “outperform” rating and a $2.00 price objective on the stock.

Senseonics Stock Performance

Shares of Senseonics stock opened at $0.60 on Monday. Senseonics has a 12 month low of $0.25 and a 12 month high of $1.40. The firm has a market capitalization of $389.72 million, a P/E ratio of -4.58 and a beta of 1.05. The business has a fifty day simple moving average of $0.65 and a two-hundred day simple moving average of $0.63. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17.

Senseonics (NYSE:SENS) last announced its quarterly earnings data on Monday, March 3rd. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same quarter in the previous year, the company earned ($0.07) EPS. On average, equities analysts forecast that Senseonics will post -0.14 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Senseonics

Several hedge funds have recently made changes to their positions in the company. First Light Asset Management LLC purchased a new position in shares of Senseonics during the 4th quarter valued at approximately $3,366,000. Jane Street Group LLC boosted its position in shares of Senseonics by 6,694.1% during the 4th quarter. Jane Street Group LLC now owns 6,118,786 shares of the company’s stock valued at $3,203,000 after acquiring an additional 6,028,726 shares during the last quarter. Renaissance Technologies LLC acquired a new position in shares of Senseonics in the 4th quarter valued at $720,000. Informed Momentum Co LLC acquired a new stake in Senseonics in the 1st quarter valued at approximately $559,000. Finally, Millennium Management LLC increased its stake in Senseonics by 299.0% during the 4th quarter. Millennium Management LLC now owns 1,088,029 shares of the company’s stock worth $569,000 after buying an additional 815,332 shares during the period. 12.36% of the stock is owned by institutional investors and hedge funds.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.